Sarah Ng
MBChB, MRCP (UK)
Clinical Research Fellow
Sarah obtained her Bachelor of Medicine, Bachelor of Surgery from the University of Edinburgh in 2011. She completed her foundation training in Oxford and moved to the North West to take up an NIHR Academic Clinical Fellowship post, where she completed her MRCP and a Post-Graduate Certificate in Global Health from the University of Edinburgh. She commenced dual specialty training in Nephrology and Intensive Care Medicine in 2015. She sits on the Faculty of Intensive Care Medicine e-Portfolio sub-committee and is also Focussed Intensive Care Echocardiography (FICE) accredited. She is currently working as a clinical research fellow on the EMPA-KIDNEY trial.
Recent publications
-
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645
-
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
-
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
-
Haemodialysis, blood pressure and risk: at the limit of non-randomized evidence.
Other
Ng SYA. et al, (2020), Nephrol Dial Transplant
-
In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.
Journal article
Ai Ng SY. et al, (2020), Ann Intern Med, 172